Module	Size	Rank	pEnrichment.Bonferroni	Fraction	Ontology	TermName
0	8285	1	5.9e-08	0.77	CC	intracellular
0	8285	2	6.5e-08	0.76	CC	intracellular part
0	8285	3	4.9e-06	0.19	BP	small molecule metabolic process
0	8285	4	0.00014	0.66	CC	intracellular organelle
0	8285	5	0.0012	0.6	CC	membrane-bounded organelle
0	8285	6	0.0014	0.6	CC	intracellular membrane-bounded organelle
0	8285	7	0.0026	0.056	MF	RNA binding
0	8285	8	0.0031	0.1	CC	mitochondrion
0	8285	9	0.0093	0.046	BP	RNA processing
0	8285	10	0.012	0.045	BP	mRNA metabolic process
0	8285	11	0.014	0.15	CC	organelle membrane
0	8285	12	0.023	0.036	CC	ribonucleoprotein complex
0	8285	13	0.064	0.56	BP	cellular metabolic process
0	8285	14	0.19	0.082	CC	Golgi apparatus
0	8285	15	0.37	0.87	CC	cell
0	8285	16	0.38	0.87	CC	cell part
0	8285	17	0.43	0.052	CC	mitochondrial part
0	8285	18	0.53	0.27	BP	gene expression
0	8285	19	0.64	0.04	BP	cellular carbohydrate metabolic process
0	8285	20	0.81	0.59	CC	cytoplasm
1	95	1	1.1e-14	0.39	BP	defense response
1	95	2	4.9e-12	0.36	BP	immune response
1	95	3	8.8e-12	0.45	BP	immune system process
1	95	4	2.4e-08	0.28	BP	regulation of immune system process
1	95	5	2.3e-06	0.56	CC	cell periphery
1	95	6	3.2e-06	0.49	BP	response to stress
1	95	7	4.5e-06	0.55	CC	plasma membrane
1	95	8	4.8e-06	0.2	BP	regulation of immune response
1	95	9	6.6e-05	0.18	BP	inflammatory response
1	95	10	9.6e-05	0.15	BP	leukocyte migration
1	95	11	0.00014	0.19	BP	positive regulation of immune system process
1	95	12	0.00026	0.11	BP	immune response-activating cell surface receptor signaling pathway
1	95	13	0.00026	0.27	BP	response to wounding
1	95	14	0.00033	0.11	BP	immune response-regulating cell surface receptor signaling pathway
1	95	15	0.00034	0.18	BP	innate immune response
1	95	16	0.00047	0.6	CC	membrane part
1	95	17	0.00069	0.15	BP	positive regulation of immune response
1	95	18	0.00082	0.36	CC	plasma membrane part
1	95	19	0.001	0.71	BP	response to stimulus
1	95	20	0.0012	0.53	CC	intrinsic to membrane
2	93	1	9.2e-59	0.72	BP	mitotic cell cycle
2	93	2	8.5e-57	0.75	BP	cell cycle process
2	93	3	3.8e-54	0.8	BP	cell cycle
2	93	4	8.3e-35	0.46	BP	M phase
2	93	5	9.9e-32	0.4	BP	mitosis
2	93	6	2.4e-31	0.52	BP	DNA metabolic process
2	93	7	3e-31	0.4	BP	M phase of mitotic cell cycle
2	93	8	1e-28	0.41	BP	regulation of cell cycle process
2	93	9	1.1e-28	0.48	BP	regulation of cell cycle
2	93	10	3e-28	0.34	BP	DNA replication
2	93	11	2.8e-27	0.4	BP	cell division
2	93	12	7.9e-26	0.39	BP	interphase of mitotic cell cycle
2	93	13	1.3e-25	0.39	BP	interphase
2	93	14	5.1e-25	0.33	BP	regulation of cell cycle arrest
2	93	15	1.3e-24	0.32	BP	cell cycle checkpoint
2	93	16	2e-22	0.37	BP	negative regulation of cell cycle
2	93	17	4.6e-22	0.34	BP	cell cycle arrest
2	93	18	6e-21	0.38	CC	chromosome
2	93	19	9e-21	0.59	BP	organelle organization
2	93	20	7.4e-19	0.62	CC	nuclear part
3	86	1	3.7e-43	0.51	CC	extracellular matrix
3	86	2	1.4e-32	0.59	CC	extracellular region part
3	86	3	1.9e-32	0.41	CC	proteinaceous extracellular matrix
3	86	4	6.2e-29	0.66	CC	extracellular region
3	86	5	1.8e-20	0.26	CC	extracellular matrix part
3	86	6	5e-19	0.2	MF	extracellular matrix structural constituent
3	86	7	3.4e-17	0.19	CC	collagen
3	86	8	1.1e-12	0.19	BP	extracellular matrix organization
3	86	9	1.1e-12	0.19	BP	extracellular structure organization
3	86	10	7.2e-11	0.33	CC	extracellular space
3	86	11	1.8e-10	0.093	MF	platelet-derived growth factor binding
3	86	12	6.9e-10	0.12	BP	cellular response to amino acid stimulus
3	86	13	1.7e-09	0.3	BP	cardiovascular system development
3	86	14	2.4e-09	0.12	BP	cellular response to acid
3	86	15	7.2e-09	0.12	BP	cellular response to organic nitrogen
3	86	16	7.2e-09	0.12	BP	cellular response to amine stimulus
3	86	17	1.9e-08	0.62	BP	multicellular organismal development
3	86	18	3.7e-08	0.081	CC	fibrillar collagen
3	86	19	7.3e-08	0.64	BP	developmental process
3	86	20	7.7e-08	0.24	MF	structural molecule activity
4	73	1	1.1e-17	0.36	BP	lymphocyte activation
4	73	2	1.3e-15	0.36	BP	leukocyte activation
4	73	3	1.6e-14	0.55	BP	immune system process
4	73	4	3.2e-13	0.42	BP	immune response
4	73	5	1.8e-12	0.37	BP	cell activation
4	73	6	1.3e-10	0.25	BP	T cell activation
4	73	7	7.3e-09	0.22	BP	regulation of lymphocyte activation
4	73	8	1.2e-08	0.33	BP	regulation of immune system process
4	73	9	1.5e-08	0.27	BP	positive regulation of immune system process
4	73	10	1.7e-07	0.22	BP	regulation of cell activation
4	73	11	1.8e-07	0.19	BP	positive regulation of cell activation
4	73	12	2.6e-07	0.18	BP	lymphocyte differentiation
4	73	13	3.4e-07	0.25	BP	regulation of immune response
4	73	14	4.5e-07	0.15	BP	antigen receptor-mediated signaling pathway
4	73	15	5.3e-07	0.18	BP	regulation of T cell activation
4	73	16	5.3e-07	0.18	BP	positive regulation of lymphocyte activation
4	73	17	8.8e-07	0.14	BP	T cell receptor signaling pathway
4	73	18	9e-07	0.082	CC	T cell receptor complex
4	73	19	9.3e-07	0.15	BP	immune response-activating cell surface receptor signaling pathway
4	73	20	1.2e-06	0.15	BP	immune response-regulating cell surface receptor signaling pathway
5	23	1	0.072	0.39	BP	cell adhesion
5	23	2	0.092	0.26	CC	proteinaceous extracellular matrix
5	23	3	0.31	0.26	CC	extracellular matrix
5	23	4	1	0.087	BP	lung vasculature development
5	23	5	1	0.087	BP	embryonic digestive tract morphogenesis
5	23	6	1	0.087	BP	blood coagulation, intrinsic pathway
5	23	7	1	0.22	BP	muscle structure development
5	23	8	1	0.087	BP	embryonic digestive tract development
5	23	9	1	0.39	CC	extracellular region
5	23	10	1	0.3	CC	extracellular region part
5	23	11	1	0.087	BP	lung morphogenesis
5	23	12	1	0.17	BP	regulation of cell adhesion
5	23	13	1	0.26	BP	embryo development
5	23	14	1	0.17	BP	cell-cell adhesion
5	23	15	1	0.13	BP	lung development
5	23	16	1	0.13	BP	branching morphogenesis of a tube
5	23	17	1	0.17	BP	muscle organ development
5	23	18	1	0.087	BP	lung alveolus development
5	23	19	1	0.13	BP	respiratory tube development
5	23	20	1	0.087	BP	somitogenesis